"cancer immunotherapy" trang 1 - tải miễn phí từ tailieunhanh
ADVANCEMENTS IN TUMOR IMMUNOTHERAPY AND CANCER VACCINES

ADVANCEMENTS IN TUMOR IMMUNOTHERAPY AND CANCER VACCINES
228    62    0
Innate Immune Regulation and Cancer Immunotherapy

Innate Immune Regulation and Cancer Immunotherapy
489    56    0
Cancer immunotherapy: A review

Cancer immunotherapy: A review
7    69    0
Pan-cancer analysis: Predictive role of TAP1 in cancer prognosis and response to immunotherapy

Pan-cancer analysis: Predictive role of TAP1 in cancer prognosis and response to immunotherapy
17    6    1
Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: A retrospective cohort study

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: A retrospective cohort study
10    2    1
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
11    82    1
A new risk model based on a 11-m6 A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

A new risk model based on a 11-m6 A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
11    20    1
Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
15    7    1
Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach

Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non–small cell lung cancer: A modelling approach
10    7    1
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial
8    63    0
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative

Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: A retrospective analysis from the I-O Optimise initiative
13    52    1
Pan-cancer analysis of TASL: A novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction

Pan-cancer analysis of TASL: A novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
22    3    1
Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
17    1    1
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer
15    8    1
The neoepitope landscape of breast cancer: Implications for immunotherapy

The neoepitope landscape of breast cancer: Implications for immunotherapy
10    36    1
Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancer

Patient stratification based on urea cycle metabolism for exploration of combination immunotherapy in colon cancer
15    2    1
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: A propensity score-matched analysis of real-world data

Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: A propensity score-matched analysis of real-world data
10    91    0
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
9    45    1
Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review

Current state of knowledge on immunotherapy in ECOG PS 2 patients. A systematic review
7    31    1
Management of metastatic melanoma in Texas: Disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors

Management of metastatic melanoma in Texas: Disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors
11    1    1